CN115427052A - 线粒体加强疗法 - Google Patents
线粒体加强疗法 Download PDFInfo
- Publication number
- CN115427052A CN115427052A CN202180024268.7A CN202180024268A CN115427052A CN 115427052 A CN115427052 A CN 115427052A CN 202180024268 A CN202180024268 A CN 202180024268A CN 115427052 A CN115427052 A CN 115427052A
- Authority
- CN
- China
- Prior art keywords
- cells
- mitochondria
- mitochondrial
- cell
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0635—B lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2307—Interleukin-7 (IL-7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Gynecology & Obstetrics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003174P | 2020-03-31 | 2020-03-31 | |
| US63/003,174 | 2020-03-31 | ||
| US202063118569P | 2020-11-25 | 2020-11-25 | |
| US63/118,569 | 2020-11-25 | ||
| PCT/IL2021/050349 WO2021199032A1 (en) | 2020-03-31 | 2021-03-29 | Mitochondrial augmentation therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115427052A true CN115427052A (zh) | 2022-12-02 |
Family
ID=77928517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180024268.7A Pending CN115427052A (zh) | 2020-03-31 | 2021-03-29 | 线粒体加强疗法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230338427A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4125959A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7825866B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220161326A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115427052A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021248780A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022019432A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3173425A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2022013978A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL296786A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022012233A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021199032A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12329781B2 (en) | 2018-07-22 | 2025-06-17 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of renal diseases |
| JP7524157B2 (ja) | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| US12502408B2 (en) | 2018-07-22 | 2025-12-23 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| WO2020021535A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of ocular diseases |
| MX2022012157A (es) | 2020-03-31 | 2023-02-15 | Minovia Therapeutics Ltd | Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas. |
| WO2023060212A1 (en) * | 2021-10-06 | 2023-04-13 | Cellvie Inc. | Enhancing adoptive cell transfer by promoting a superior population of adaptive immune cells |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110621774A (zh) * | 2016-10-14 | 2019-12-27 | 儿童医疗中心有限公司 | 用于治疗中枢神经系统疾病和病症的组合物和方法 |
| WO2020021539A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of muscle diseases |
| WO2020021541A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria |
| WO2020021538A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of brain diseases |
| WO2020021537A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of liver diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180030413A1 (en) * | 2015-02-26 | 2018-02-01 | Minovia Therapeutics Ltd. | Mammalian cells enriched with functional mitochondria |
| EP3823644A4 (en) * | 2018-07-22 | 2022-06-08 | Minovia Therapeutics Ltd. | MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES |
| US12502408B2 (en) * | 2018-07-22 | 2025-12-23 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
-
2021
- 2021-03-29 CN CN202180024268.7A patent/CN115427052A/zh active Pending
- 2021-03-29 WO PCT/IL2021/050349 patent/WO2021199032A1/en not_active Ceased
- 2021-03-29 BR BR112022019432A patent/BR112022019432A2/pt not_active Application Discontinuation
- 2021-03-29 US US17/912,022 patent/US20230338427A1/en active Pending
- 2021-03-29 MX MX2022012233A patent/MX2022012233A/es unknown
- 2021-03-29 CA CA3173425A patent/CA3173425A1/en active Pending
- 2021-03-29 IL IL296786A patent/IL296786A/en unknown
- 2021-03-29 EP EP21779142.5A patent/EP4125959A4/en active Pending
- 2021-03-29 AU AU2021248780A patent/AU2021248780A1/en active Pending
- 2021-03-29 JP JP2022559816A patent/JP7825866B2/ja active Active
- 2021-03-29 KR KR1020227033647A patent/KR20220161326A/ko not_active Ceased
-
2022
- 2022-09-29 CO CONC2022/0013978A patent/CO2022013978A2/es unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110621774A (zh) * | 2016-10-14 | 2019-12-27 | 儿童医疗中心有限公司 | 用于治疗中枢神经系统疾病和病症的组合物和方法 |
| WO2020021539A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of muscle diseases |
| WO2020021541A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria |
| WO2020021538A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of brain diseases |
| WO2020021537A1 (en) * | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of liver diseases |
Non-Patent Citations (1)
| Title |
|---|
| 师蕾;常春康;: "间充质干细胞在骨髓增生异常综合征发病机制中的研究进展", 诊断学理论与实践, no. 01, 25 February 2018 (2018-02-25), pages 128 - 131 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20230338427A1 (en) | 2023-10-26 |
| AU2021248780A1 (en) | 2022-11-10 |
| JP2023519744A (ja) | 2023-05-12 |
| WO2021199032A1 (en) | 2021-10-07 |
| BR112022019432A2 (pt) | 2022-12-06 |
| EP4125959A1 (en) | 2023-02-08 |
| JP7825866B2 (ja) | 2026-03-09 |
| CA3173425A1 (en) | 2021-10-07 |
| MX2022012233A (es) | 2023-03-08 |
| IL296786A (en) | 2022-11-01 |
| EP4125959A4 (en) | 2024-07-10 |
| KR20220161326A (ko) | 2022-12-06 |
| CO2022013978A2 (es) | 2022-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7825866B2 (ja) | ミトコンドリア増強療法 | |
| US20250101381A1 (en) | Cells with increased immuno-regulatory properties and methods for their use and manufacture | |
| US12605410B2 (en) | Mitochondria-enriched genetically engineered cells and uses thereof | |
| Devine et al. | Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion | |
| JP7522095B2 (ja) | 原発性ミトコンドリア病のためのミトコンドリア増強療法 | |
| US20220380727A1 (en) | Generation of engineered regulatory t cells | |
| CN112601532A (zh) | 使用富集有功能性线粒体的干细胞的线粒体增强疗法 | |
| JP2021532091A (ja) | 膵臓疾患のミトコンドリア増強療法 | |
| JP2021532095A (ja) | 肝臓疾患のミトコンドリア増強療法 | |
| US20230392118A1 (en) | Generation of cd4+ effector and regulatory t cells from human pluripotent stem cells | |
| US20230392168A1 (en) | Compositions and methods related to megakaryocyte-derived extracellular vesicles for treating myeloproliferative neoplasms | |
| CN116396940A (zh) | 造血干祖细胞及其制备方法和用途 | |
| US20220184137A1 (en) | Correction of Beta-Thalassemia Phenotype by Genetically Engineered Hematopoietic Stem Cell | |
| WO1998012304A1 (en) | Culture system for hematopoietic stem cells | |
| CN101083910B (zh) | 用于预防和治疗移植中的免疫应答的肝脏基质细胞 | |
| JP2024546826A (ja) | 骨髄異形成症候群のためのミトコンドリア増強療法 | |
| CN117015552A (zh) | 用于治疗骨髓增殖性肿瘤的与巨核细胞来源的细胞外囊泡相关的组合物和方法 | |
| US20200263141A1 (en) | Multi-Chimeric Cell and Therapy for Transplantation and Treatment of Immune Deficiencies and Genetic Disorders | |
| HK40046349A (en) | Cells with increased immuno-regulatory properties and methods for their use and manufacture | |
| Horwitz | Future Directions in Pediatric Stem-Cell Transplantation | |
| MX2007008437A (es) | Celulas estromales de medula osea para inmunoproteccion de celulas madre neurales transplantadas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |